ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Aligning Global Standards For ICH E6(R3) And Artificial Intelligence

  Global standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.

• AI‑Readiness Checklist: Is Your Clinical Data Environment Ready?

  AI impact depends on solid data practices, good governance, and team alignment. This piece highlights what to assess and how organizations can build readiness for future initiatives.

• Wearables In Clinical Trials: Real Benefits Beyond The Hype

  Gain insight into the slow adoption rates and consider several compelling reasons why researchers should integrate these devices sooner rather than later.

• Implementing ICH E6 (R3) In A Risk Averse Culture

  Get several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.

• What Is Ontology? Learn About The Data Layer That Makes Agentic AI Work

   Get an overview of ontology, the "semantic translator" that determines whether your AI investments actually compound or stay forever siloed.

• A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients

  Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.

• Televisits: Why Integrate Telemedecine Features In eCOA Trials?

  Discover new possibilities where patients can complete several of their clinical study procedures remotely, making their participation in clinical trials easier and less cumbersome than site-based trials.

• Comprehensive Data Management For Non-Interventional Research

  Learn how your teams can embrace end-to-end clinical trial data platforms for non-interventional studies to improve user experience, boost patient engagement, ensure data quality, and achieve study success.

• How Can Sponsors Enable Research-Naïve Clinical Trial Sites

  Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.

• Reinventing Prostate Cancer Diagnostics With An All-In-One Platform

  Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.